Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:740 (25 September), doi:10.1136/bmj.329.7468.740-a
| The first 150 words of the full text of this article appear below. |
EDITORThe values of the National Institute for Clinical Excellence (NICE) turn out to be utilitarian and economic.1 Predictably, NICE's attempt to use them to generate advice to professionals for achieving the highest attainable standard of care often founders on the narrowness of perspective. High quality care demands an understanding of human suffering that transcends the urge to fix biological machine faults.
Take obesity. In 2001 NICE approved the prescription of orlistat and sibutramine to obese patients, a tiresome diversion in the face of a developed world pandemic of obesity. Obesity is about consumption, and consumption is woven into the fabric of society. No amount of medical technology or guidelines stands any meaningful chance of changing this. The problem is cultural, and the solutions are political and educational.
We might be spared these distractions if NICE added two new questions to their appraisals.
Firstly, is the problem for which
William House, general practitioner
St Augustine's Practice, Keynsham, Bristol BS31 2BN thehouses@supanet.com
David Peters, trustee, British Holistic Medical Association
School of Integrated Health, Euston Building, University of Westminster, London W1W 6UW